Physician profile
Michael J Gardner
NPI 1710101555
$2,942,712.78
in general payments reported to CMS, 2019-2025
25 companies · $891K in 2025
The $891K reported for 2025 was more than what 99% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215K · 2020: $169K · 2021: $107K · 2022: $423K · 2023: $557K · 2024: $580K · 2025: $891K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.8M · Consulting Fee: $147K · Travel and Lodging: $57K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,421 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,802,259.32 |
| Consulting Fee | $147,322.17 |
| Travel and Lodging | $57,270.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,622.50 |
| Food and Beverage | $4,421.34 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,149,843.98 | 2019-2025 | |
| Depuy Synthes Products, INC. | $1,052,985.38 | 2019-2025 | Na |
| Globus Medical, INC. | $153,129.64 | 2019-2025 | Ankle Fracture System, Tlif, Mini Fragment System |
| Medical Device Business Services, INC. | $143,638.69 | 2019-2025 | Expedium, Lcp, Attune |
| Kci USA, INC. | $141,619.23 | 2019-2023 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Stryker Corporation | $136,194.02 | 2019-2025 | Gamma, Augment Injectable, Axsos |
| Flower Orthopedics Coporation | $89,415.77 | 2020-2025 | Fibula Nail, 3.5mm X 130mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread |
| Synthes Gmbh | $27,730.89 | 2019-2024 | |
| Synthes USA Products LLC | $23,740.78 | 2019-2022 | |
| Osteocentric Technologies, INC. | $9,213.68 | 2019-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Conventus Orthopaedics, INC. | $7,500.00 | 2019-2020 | |
| Solventum Corporation | $3,709.37 | 2024-2025 | Prevena, Prevena Restor Arthroform, Prevena Restor Axioform |
| Depuy Synthes Sales INC. | $1,370.31 | 2019-2024 | Na |
| Orthoxel Designated Activity Company | $1,000.00 | 2019-2020 | |
| Evolution Surgical, INC | $273.69 | 2023-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $242.78 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $237.47 | 2019-2020 | |
| Paragon 28, INC. | $159.56 | 2024 | Phantom Fibula Nail |
| Orthofix Medical, INC. | $156.25 | 2024 | Truelok Evo |
| Kerecis Limited | $145.15 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $110.90 | 2023 | Avance Nerve Graft |
| Innovation Technologies INC | $105.92 | 2025 | Irrisept |
| Nuvasive Specialized Orthopedics, INC. | $95.64 | 2023 | Precice Intramedullary Limb Lengthening System |
| Acera Surgical, INC. | $86.09 | 2024 | Restrata Wound Matrix |
| My01 INC. | $7.59 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,684.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.